Vontobel Holding’s AstraZeneca AZN Stock Holding History

Vontobel Holding’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$56.1M	Buy	288,690 +284,494	+6,780%	+$54.9M	0.19%	109
2025 Q4	$771K	Sell	4,196 -767	-15%	-$135K	﹤0.01%	835
2025 Q3	$761K	Hold	4,963	–	–	﹤0.01%	809
2025 Q2	$694K	Buy	4,963 +17	+0.3%	+$2.38K	﹤0.01%	799
2025 Q1	$727K	Buy	+4,946	New	+$716K	﹤0.01%	679
2023 Q4	–	Sell	-4,220	Closed	-$572K	–	1112
2023 Q3	$572K	Buy	4,220 +119	+3%	+$16.3K	0.01%	727
2023 Q2	$587K	Buy	4,101 +96	+2%	+$14.1K	0.01%	751
2023 Q1	$556K	Buy	4,005 +2,452	+158%	+$330K	0.01%	755
2022 Q4	$210K	Sell	1,553 -678	-30%	-$85K	﹤0.01%	985
2022 Q3	$245K	Buy	2,231 +678	+44%	+$86K	﹤0.01%	901
2022 Q2	$208K	Buy	+1,553	New	+$204K	﹤0.01%	932

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Vontobel Holding's AZN Position: Q1 2026 in Review

Vontobel Holding increased its AstraZeneca (AZN) stake by 6,780% in Q1 2026, buying an estimated $54.9M and bringing the position to 288,690 shares worth $56.1M. The position accounts for 0.19% of the portfolio, ranked #109.

Vontobel Holding first reported a position in AZN in Q2 2022 and has held it in 11 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Vontobel Holding held 288,690 shares of AstraZeneca worth $56.1M as of Q1 2026.
Vontobel Holding bought 284,494 AstraZeneca shares in Q1 2026, an estimated $54.9M.
AstraZeneca made up 0.19% of Vontobel Holding's portfolio in Q1 2026, its #109 holding.
Vontobel Holding first reported a position in AstraZeneca in Q2 2022 and has held it in 11 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.